Upcoming Webinars

Bone Club Series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization. Part two willl focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three will addresses the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions. 

Part 1: How I Do It—From Imaging Workup to Intervention: Metastatic/Malignant Bone Lesions

Wednesday, 24 September 2025 | 7 – 8:30 p.m. ET

Faculty 

Moderator

headshot

Gina Landinez, MD

Baptist Health South Florida, Miami Vascular Specialists

Faculty Panel

Jason Levy MD, FSIR

Northside Radiology Associates

Alex Kim

Marwan Moussa, MD

Beth Israel Deaconess Medical Center

Brandon Key, MD

Froedtert & Medical College of Wisconsin

Register Now

Part 2: How I Do It—From Imaging Workup to Intervention: Benign MSK Lesions

Wednesday, 8 October 2025 | 7 – 8:30 p.m. ET

Faculty 

Moderator

headshot

Sirish Kishore, MD

Stanford University

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Alex Kim

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Wednesday, 11 November 2025 | 7 – 8:30 p.m. ET– 8:30 p.m. ET

Faculty

Moderator

headshot

Sirish Kishore, MD 

Stanford University 

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Alex Kim

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

Bone Club is supported by:

Medtronic Stryker Varian

 


Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma

Postponed: Stay tuned for more details 

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies. 

Faculty

Rahul Sheth, MD, FSIR

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by:

AstraZeneca Varian
 

Advancing Ablation: Clinical Perspectives on Emprint™ and OsteoCool™

Thursday, 25 September 2025 | 6 – 7 p.m. ET

This panel discussion will feature leading interventional radiologists sharing their clinical experience with microwave and radiofrequency ablation technologies — specifically Emprint™ Microwave Ablation and OsteoCool™ RF Ablation. The session will highlight treatment strategies, case insights, and procedural considerations across soft tissue and bone tumor applications.

Faculty

Moderator

Jack Jennings
 

Jack Jennings, MD, PhD, FSIR

Washington University School of Medicine

Faculty Panel

Jawad Hussain
 

Jawad Hussain, MD, MS

Commonwealth Interventional Radiology

Nicole Keefe
 

Nicole Keefe, MD

University of North Carolina

Rahul Sheth
 

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Register Now

This webinar is sponsored by


Advancing HCC Treatment: Sequencing Strategies and Managing Combination Therapies

Tuesday, 30 September 2025 | 7 – 8 p.m. ET

Join SIO for a three-part HCC webinar series this fall. This webinar will cover advances in treatment of hepatocellular carcinoma (HCC) with a shift towards combination therapies and sequencing strategies to optimize patient outcomes. 

Faculty

Moderator

David Hirschl
 

Julius Chapiro, MD, PhD

Yale University

Faculty

David Hirschl

Richard Finn, MD

University of California Los Angeles

Willian Moore, MD

Nicholas Fidelman, MD

University of California San Francisco 

Register Now

This webinar is sponsored by:

 

Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Wednesday, 22 October 2025 | 7 p.m. ET

Join SIO for a three-part HCC webinar series this fall. This webinar will cover the role of immunotherapy as a treatment for HCC and in combination with locoregional therapies, as well as looking at mechanisms of resistance, biomarker predictions and other therapeutic targets.

Faculty

Moderator

David Hirschl
 

Julius Chapiro, MD, PhD

Yale University

Faculty

David Hirschl

Terrance Gade, MD, PhD

University of Pennsylvania 

Sarah Manes

Sarah Manes

Global Liver Institute

Willian Moore, MD

Anjana Pillai, MD

University of Chicago

Willian Moore, MD

Michael Soulen, MD

University of Pennsylvania 

Register Now

This webinar is sponsored by:

 

Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7 p.m. ET

This webinar, funded by AstraZeneca, will cover ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

 

Faculty

Moderator

Tim McClure
 

Zach Berman, MD

UC San Diego 

Faculty

Adam Burgoyne, MD, PhD
 

Adam Burgoyne, MD, PhD

UC San Diego

Brian Welch, MD
 

Kirema Garcia-Reyes, MD

Mount Sinai

David Woodrum, MD, PhD
 

Christopher Malone, MD

Washington University 

 

Register Now

This webinar is sponsored by:

Boston Scientific Stryker